New
Fda Approves First Rapid-acting Insulin Biosimilar For Patients With Diabetes
The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Popular Products
-
Black Cumin Seed Oil & Ashwagandha$43.99$29.78 -
Shilajit Capsules for Strength & Vita...$43.99$29.78 -
Pre-Workout Supplement for Strength, ...$43.99$29.78 -
Centrum Multivitamin for Energy, Immu...$43.99$29.78 -
Bee Venom Glucosamine Capsules for Jo...$43.99$29.78